Atamestane

Atamestane (developmental code name SH-489), also known as metandroden, as well as 1-methylandrosta-1,4-diene-3,17-dione, is a steroidal aromatase inhibitor that was studied in the treatment of cancer.[1] It blocks the production of estrogen in the body. The drug is selective, competitive, and irreversible in its inhibition of aromatase.[2]

Atamestane

Clinical data
Other names	SH-489; Metandroden; 1-Methylandrosta-1,4-diene-3,17-dione
ATC code	None
Legal status
Legal status	UK: Class C
Identifiers
IUPAC name (8R,9S,10S,13S,14S)-1,10,13-Trimethyl-7,8,9,11,12, 14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
CAS Number	96301-34-7
PubChem CID	57050
ChemSpider	51438
UNII	62GA3K28B6
ChEMBL	ChEMBL2105987
Chemical and physical data
Formula	C20H26O2
Molar mass	298.426 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=C\1/C=C(/C)[C@]4(C(=C/1)/CC[C@@H]3[C@@H]4CC[C@@]2(C(=O)CC[C@H]23)C)C
InChI InChI=1S/C20H26O2/c1-12-10-14(21)11-13-4-5-15-16-6-7-18(22)19(16,2)9-8-17(15)20(12,13)3/h10-11,15-17H,4-9H2,1-3H3/t15-,16-,17-,19-,20-/m0/s1 Key:PEPMWUSGRKINHX-TXTPUJOMSA-N
(what is this?)  (verify)

See also

• Boldione (androsta-1,4-diene-3,17-dione)

References

1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 794–. ISBN 978-1-4757-2085-3.
2. el Etreby MF (March 1993). "Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review". The Journal of Steroid Biochemistry and Molecular Biology. 44 (4–6): 565–72. doi:10.1016/0960-0760(93)90260-4. PMID 7682838. S2CID 53256276.

External links

• Atamestane entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from the U.S. National Cancer Institute document: "Dictionary of Cancer Terms".